Saturday, August 19, 2017 10:11:50 PM
History
Founder
Prof. Lugee Li is the founder and sole shareholder of Leader Biomedical Group. Originally a materials engineer, Prof. Lugee Li is also the Founder and Chairman of Dongguan Eontec, a new materials company listed on the Shenzen Stock exchange.
Prof. Lugee Li currently heads China’s magnesium research initiate, which led him to team up with German companies to investigate the applications of magnesium in the medical field. It is this initiative that led to his entry into the field of medical devices.
2012: Foundation
Prof. Lugee Li recruits Leo Liyeung, Lili Yao, and Isaac Bresnick to help found Leader Biomedical.
2013: Acquisition of aap Joints
Prof. Lugee Li acquires a majority stake in aap Joints, the reconstructive implants division of aap Implantate in Berlin, Germany.
2014: Acquisition of EMCM and formation of Leader Biomedical Group
Having identified the synergies between biomaterials and surgical implants within the Chinese market, Prof. Lugee Li acquired EMCM, a biomaterials contract manufacturer, from aap Implantate. Subsequent to the acquisition, an organisation was established to support the future growth plans of the business with the appointment of Basil Babychan to the Board of Management and the establishment of Leader Biomedical’s HQ in Hong Kong, China, and Leader Biomedical Europe in Amsterdam, the Netherlands.
2015: Global expansion of Leader Biomedical Group
Leader Biomedical expanded its global footprint with the establishment of Leader Biomedical Brazil, in Sao Paulo, and Leader Biomedical India, in Bangalore.
2016: Further increase of Leader Biomedical Group’s global footprint
Leader Biomedical Group partners with BioTiss Austria in new eCOO® Technology venture and establishes two more regional ventures with Leader Biomedical Leader Biomedical RUS, LLC, in Moscow, in the Russian Federation, and Leader Biomedical ASIA PACIFIC SDN.BHD (Leader Biomedical APAC), in Selangor, Malaysia .
Recent LQMT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:11:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:49:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM